Inhalation Anesthesia Market by Product (Sevoflurane, Isoflurane, and Desflurane); By Application (Induction, and Maintenance); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026

Check Today's Best Price

$3500 Buy Now
The Global Inhalation Anesthesia market was approximately valued at $1.33 billion at 2018, with a projected CAGR of 4.1% during the forecast period.
  • Market Overview

    The Global Inhalation Anesthesia market was approximately valued at $1.33 billion at 2018, with a projected CAGR of 4.1% during the forecast period. Inhalation anesthesia are used for induction and maintenance of general anesthesia and sedation. They are administered by the facemask and a tracheal tube connected to the vaporizer and another delivery system.

    Market Dynamics

    Increasing number of surgeries worldwide, increasing prevalence of cancer, cardiovascular, respiratory, neurological, gastrointestinal, orthopedic, and spinal diseases and disorders, and advantages such as short duration and predictable nature of inhalation anesthesia are the major factors driving the growth of the global inhalation anesthesia market. However, high cost involved in the performance testing of medical products may hamper the market from growing. Moreover, increasing number of orthopedic procedures such as ligament and access to universal health insurance coverage for a wider population base coupled with constant improvements in healthcare infrastructure in various developing countries is likely to gain significant impetus for the inhalation anesthesia market share in the coming years.

    Market Segmentation

    The study provides a crucial view of the inhalation anesthesia by segmenting the market based on the product, application, and geography. The product segment includes sevoflurane, isoflurane, and desflurane. Induction, and maintenance are the classification of the application segment. Furthermore, geographical coverage has been offered for each of the major regions including North America, Asia-Pacific, Europe, Row, and South America.

    Scope of the Global Inhalation Anesthesia Market

    By Product

    • Sevoflurane
    • Isoflurane
    • Desflurane

    By Application

    • Induction
    • Maintenance

    By Geography

    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • France
      • Germany
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Korea
      • Rest of APAC
    • South America
      • Brazil
      • Rest of South America
    • Rest of the World
      • Middle East
      • Africa
    keyboard_arrow_up
  • TABLE OF CONTENTS

    Chapter 1 Introduction
    1.1 Executive Summary
    1.2 Market Definition
    1.3 Market Scope

    Chapter 2 Research Methodology
    2.1 Primary Research
    2.2 Research Methodology
    2.3 Assumptions & Exclusions
    2.4 Secondary Data Sources

    Chapter 3 Market Overview
    3.1 Report Segmentation & Scope
    3.2 Key Market Trends
    3.2.1 Drivers
    3.2.2 Restraints
    3.2.3 Opportunities
    3.3 Porter’s Five Forces Analysis
    3.4 Market Share Analysis

    Chapter 4 Global Inhalation Anesthesia Market by Product Type: Market Size and Forecast, 2018 – 2026
    4.1 Introduction
    4.1.1 Market Size and Forecast
    4.2 Sevoflurane
    4.2.1 Market Size and Forecast
    4.3 Isoflurane
    4.3.1 Market Size and Forecast
    4.4 Desflurane
    4.4.1 Market Size and Forecast

    Chapter 5 Global Inhalation Anesthesia Market by Application: Market Size and Forecast, 2018 – 2026
    5.1 Introduction
    5.1.1 Market Size and Forecast
    5.2 Induction
    5.2.1 Market Size and Forecast
    5.3 Maintenance
    5.3.1 Market Size and Forecast

    Chapter 6 Global Inhalation Anesthesia Market by Geography: Market Size and Forecast, 2018 – 2026
    6.1 Introduction
    6.1.1 Market Size and Forecast
    6.2 North America
    6.2.1 North America Market Size & Forecast, By Country
    6.2.2 North America Market Size & Forecast, By Product Type
    6.2.3 North America Market Size & Forecast, By Application
    6.2.4 The U.S.
    6.2.4.1 Market Size and Forecast
    6.2.5 Canada
    6.2.5.1 Market Size and Forecast
    6.2.6 Mexico
    6.2.6.1 Market Size and Forecast
    6.3 Europe
    6.3.1 Europe Market Size and Forecast, By Country
    6.3.2 Europe Market Size and Forecast, By Product Type
    6.3.3 Europe Market Size and Forecast, By Application
    6.3.4 UK
    6.3.4.1 Market Size and Forecast
    6.3.5 Germany
    6.3.5.1 Market Size and Forecast
    6.3.6 France
    6.3.6.1 Market Size and Forecast
    6.3.7 Italy
    6.3.7.1 Market Size and Forecast
    6.3.8 Spain
    6.3.8.1 Market Size and Forecast
    6.3.9 Rest of Europe
    6.3.9.1 Market Size and Forecast
    6.4 Asia-Pacific
    6.4.1 Asia-Pacific Market Size and Forecast, By Country
    6.4.2 Asia-Pacific Market Size and Forecast, By Product Type
    6.4.3 Asia-Pacific Market Size and Forecast, By Application
    6.4.4 India
    6.4.4.1 Market Size and Forecast
    6.4.5 China
    6.4.5.1 Market Size and Forecast
    6.4.6 Australia
    6.4.6.1 Market Size and Forecast
    6.4.7 Japan
    6.4.7.1 Market Size and Forecast
    6.4.8 South Korea
    6.4.8.1 Market Size and Forecast
    6.4.9 Rest of Asia-Pacific
    6.4.9.1 Market Size and Forecast
    6.5 South America
    6.5.1 South America Market Size and Forecast, By Country
    6.5.2 South America Market Size and Forecast, By Product Type
    6.5.3 South America Market Size and Forecast, By Application
    6.5.4 Brazil
    6.5.4.1 Market Size and Forecast
    6.5.5 Rest of South America
    6.5.5.1 Market Size and Forecast
    6.6 RoW
    6.6.1 RoW Market Size and Forecast, By Country
    6.6.2 RoW Market Size and Forecast, By Product Type
    6.6.3 RoW Market Size and Forecast, By Application
    6.6.4 Middle East
    6.6.4.1 Market Size and Forecast
    6.6.5 Africa
    6.6.5.1 Market Size and Forecast

    Chapter 7 Company Profiles
    7.1 AbbVie Inc.
    7.2 Baxter
    7.3 Fresenius Kabi AG
    7.4 Hikma Pharmaceuticals PLC
    7.5 Halocarbon Products Corporation
    7.6 Jiangsu Hengrui Medicine Co. Ltd.
    7.7 Lunan Pharmaceutical Group Co. Ltd.
    7.8 Piramal Enterprises Limited

    keyboard_arrow_up
  • Inhalation Anesthesia Market Key Players

    • AbbVie Inc.
    • Baxter
    • Fresenius Kabi AG
    • Hikma Pharmaceuticals PLC
    • Halocarbon Products Corporation
    • Jiangsu Hengrui Medicine Co. Ltd.
    • Lunan Pharmaceutical Group Co. Ltd.
    • Piramal Enterprises Limited
    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CLIENTS